1017822-04-6

Basic information

• Product Name: 4-(1-methyl-1H-benzoimidazol-2-yl)-benzoic acid methyl ester
• Synonyms: 4-(1-methyl-1H-benzoimidazol-2-yl)-benzoic acid methyl ester
• CAS NO: 1017822-04-6
• Molecular Weight: 266.299
• Mol File: 1017822-04-6.mol

Chemical Properties

• CAS DataBase Reference: 4-(1-methyl-1H-benzoimidazol-2-yl)-benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(1-methyl-1H-benzoimidazol-2-yl)-benzoic acid methyl ester(1017822-04-6)
• EPA Substance Registry System: 4-(1-methyl-1H-benzoimidazol-2-yl)-benzoic acid methyl ester(1017822-04-6)

Safety Data

• Hazardous Substances Data: 1017822-04-6(Hazardous Substances Data)

Upstream product

• 1571-08-0 methyl 4-formylbenzoate 
• 95-54-5 1,2-diamino-benzene 
• 100880-52-2 methyl 4‐(1H‐benzo[d]imidazol‐2‐yl)benzoate 
• 74-88-4 methyl iodide 
• 4760-34-3 N-methyl-1,2-phenylenediamine 

Downstream Products

• 579510-98-8 N-hydroxy-4-(1-methyl-1H-benzo[d]imidazole-2-yl)benzamide 

Relevant articles and documents

BENZO-HETEROCYCLIC COMPOUND AND COMPOSITION FOR PREVENTING OR TREATING CANCER DISEASE, CONTAINING SAME AS ACTIVE INGREDIENT

A novel benzoheterocycle compound or a pharmaceutically acceptable salt thereof showed a high anti-proliferative effect against cancer cell lines. Using this, a pharmaceutical composition for preventing or treating cancer disease can comprise the compound

3-AMINOCYCLOPENTANE CARBOXAMIDE DERIVATIVES

Compounds of the formula (I) in which R1, R4, R, X1, X2, X3, X4, q and W have the meanings indicated in Claim 1, are inhibitors of fatty acid synthase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.

AMINOALKYLAZOLE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS

The present invention provides a compound of formula I: and the use thereof for the treatment of a central nervous system disorder related to or affected by the histamine-3 receptor.